Moderna Therapeutics is banking an additional $125 million in an expanded partnership with Merck around a personalized cancer vaccine. It's now raised more than $1.6 billion in equity and $1 billion through partnership payments, CEO Stephane Bancel said in a telephone interview Thursday. The Wall Street Journal reported in March, citing an unnamed source,...